Accordingly, NECA-mediated upregulation of PD-L1 on CLL cells was abrogated upon addition of the selective A2a receptor antagonist SCH 58261, (Figure 5A,B). Here, CD274 is linked to B-cell chronic lymphocytic leukemia.